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Abstract
Recent studies have described a number of fatalities due to methicillin-resistant Staphylococcus
aureus (MRSA) and influenza virus co-infection. MRSA isolates provide a challenge to caregivers due
to inherent wide range antibiotic resistance. Many facilities have instituted screening methods,
based on the presence of antibiotic resistance genes, to identify MRSA positive patients upon
admission. However, the resistance profile of the pathogen does not necessarily determine the
severity of disease caused by that organism.
We describe a fatal case of necrotizing pneumonia in a patient co-infected with Influenza B and a
community-associated, PVL-positive methicillin-susceptible Staphylococcus aureus (MSSA).
Background
Necrotizing pneumonia due to community-associated
methicillin-resistant Staphylococcus aureus (CA-MRSA) is
increasingly reported in otherwise healthy individuals [1].
Several cases of community-associated pneumonia (CAP)
have been attributed to methicillin-resistant strains such
as the USA 300 epidemic CA-MRSA clone and are often
associated with influenza virus infection or influenza-like
illness (ILI) [2]. The USA 300 clone harbors the gene
encoding Panton-Valentine leukocidin (PVL) [3], a pore-
forming toxin that targets cells of the immune system [4].
Although the majority of CA-MRSA infections involving
skin and soft tissue likely occur independent of PVL toxin
production [5], PVL is required for lung tissue necrosis
and inflammation as present in the rare, but frequently
fatal, cases of necrotizing pneumonia[4,6]. We report here
a fatal case of necrotizing pneumonia in a patient co-
infected with Influenza B and a PVL-positive Staphylococ-
cus aureus that in contrast to recent reported cases is methi-
cillin-susceptible.
Case presentation
A previously healthy 30 year old black woman went to her
local emergency department on April 12, 2007 with a 4 to
5 day history of sore throat, chills, fever and shortness of
breath. A chest radiograph was performed and read as
clear, however detail was obscured by abundant overlying
soft tissue. She was diagnosed with bronchitis and treated
with intravenous antibiotics and steroids. She was dis-
charged to home with a prescription for albuterol and azi-
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the following morning, she developed worsening symp-
toms including hemoptysis. She was brought to the emer-
gency room by ambulance. Vital signs at time of
admission included a fever of 100.5°F (38°C), pulse of
165 bpm, and blood pressure of 104/53 mm Hg. In the
emergency room, she developed hypotension and respira-
tory failure requiring intubation. A chest x-ray revealed
bilateral pulmonary infiltrates and a right pleural effu-
sion. She had a pronounced leukopenia (0.9/mm3) with
53% neutrophils. She was admitted to the intensive care
unit with a diagnosis of septic shock with hemorrhagic
pneumonia, and was treated with ceftriaxone and moxi-
floxacin. Additional antibiotics included gentamycin, cip-
rofloxacin, piperacillin, and tazobactam. The platelet
count was initially normal but dropped quickly after
admission. Despite aggressive care, including vasopres-
sors and additional antibiotics, she died that night. A
blood culture collected prior to death was positive for Sta-
phylococcus aureus. The culture was resistant to amoxicillin,
clarithromycin, erythromycin, and penicillin, and suscep-
tible to the rest of the panel including oxacillin. The Flor-
ida Department of Health was notified of the death, as
was the Hillsborough County Medical Examiner. An
autopsy was performed the following day which revealed
bilateral necrotizing bronchopneumonia with abscess for-
mation and diffuse alveolar damage. Clusters of cocci
were seen in alveoli along with macrophages. Focally,
there was necrosis of blood vessel walls, associated with
intra-alveolar hemorrhage. Larger bronchi revealed acute
mucosal inflammation and epithelial necrosis. Acute
tubular necrosis of the kidneys was also noted.
Methods and results
Specimens from blood, right and left lung were sent to the
Florida Department of Health laboratory in Tampa. Viral
studies were positive for influenza B using an RT-PCR pro-
tocol provided by the Centers for Disease Control and Pre-
vention (Lindstrom, personal communication). Assay
specifications are available from CDC upon request. S.
aureus was cultured from blood and in tissue from both
lungs. Molecular genotyping of the S. aureus isolate was
performed using pulsed-field gel electrophoresis (PFGE)
and multi-locus variable number tandem repeat finger-
printing (MLVF) as previously described [7,8]. The result-
ing pulsotypes, which were identical for the three patient
samples, were compared to USA 300 (Figure 1) and over
400 S. aureus isolates in our database (data not shown)
and no match was identified. Comparison of the MLVF
pattern with common CA-MRSA patterns also demon-
strated no known match. The disease progression sug-
gested that this patient died of co-infection with CA-
MRSA and influenza. However, the lack of a matching
PFGE pattern in our database which consists of more than
400 CA-MRSA isolates collected in Florida over the past 5
years [7] led us to suspect this isolate was not methicillin-
resistant. Disk diffusion susceptibility testing was per-
formed as previously described [9] and the isolate proved
to be susceptible to both oxacillin and cefoxitin. Penicil-
lin-binding protein 2' detection was performed using a
slide agglutination test (Denka Seiken Co, LTD., Tokyo,
Japan), and PCR for the mecA gene was performed as pre-
viously described [10]. Results from these three tests dem-
onstrated that the patient's isolate lacks both the protein
product and the mecA gene. Microbroth dilution and Etest
also confirmed the isolate is susceptible to oxacillin con-
firming its identity as a methicillin-susceptible Staphyloco-
ccus aureus (MSSA). PCR performed as previously
described [11] demonstrated that the isolate was positive
for the PVL toxin genes.
Pulsed-field gel electrophoresisFigure 1
Pulsed-field gel electrophoresis. Lanes are as follows; 
lane M: S. aureus standard SmaI digested strain 8325, Lane 1: 
USA300 control strain, Lanes 2 and 3, patient blood and lung 
samples, respectively.
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This case was the fourth case of fatal community associ-
ated S. aureus pneumonia co-infected with influenza B
reported to the Florida Department of Health from Janu-
ary 1, 2007 through April 30, 2007. All four cases were
reported from Hillsborough County Florida, 2007 esti-
mated population 1,188,706. In contrast to the case pre-
sented herein, the three previous cases were confirmed
MRSA and each was USA300 by PFGE. These cases age 4,
14 and 18 had similar presentations and clinical course to
the MSSA case described here.
Fatal cases of community-acquired pneumonia due to co-
infection with influenza and MRSA have increasingly
been reported among previously healthy individuals [1].
In a recent morbidity and mortality weekly report, Jones-
Nazar et al. [1] reported 10 cases of MRSA CAP with pre-
ceding or concurrent ILI in Louisiana and Georgia in
which 60% of the patients succumbed to the illness.
Severe CAP was also reported in nine states during the
2003–04 influenza season, 71% of cases with demon-
strated influenza laboratory confirmation [2]. Previous
studies have reported fatal cases of necrotizing pneumo-
nia due to MSSA in patients with a history of influenza-
like syndrome [12]. Studies of pneumonia caused by PVL-
positive MRSA and MSSA have demonstrated a number of
factors which predict mortality [12,13]. These factors
included airway bleeding and leukopenia [12,13], both of
which were reported clinical findings in the case described
herein. In addition, the patient required mechanical ven-
tilation following respiratory failure which has also been
associated with fatal outcomes [13].
To our knowledge, our patient represents the first fatal
case of community-acquired pneumonia in which co-inci-
dent infection with both influenza B and PVL-positive
MSSA was laboratory confirmed.
Although MRSA is an uncommon cause of CAP, the Cent-
ers for Disease Control and Prevention has initiated active
population-based surveillance for invasive MRSA disease
in several locations in the United States [2]. A number of
healthcare facilities have initiated methods to screen
incoming patients for MRSA using nasal swabs and com-
mercially available media such as MRSAID (bioMerieux),
MRSA Select (Bio-Rad Laboratories), and CHROMagar
MRSA (Becton Dickinson Microbiology) [14]. Detection
of MRSA from nasal swabs can also be performed using
molecular techniques such as IDI-MRSA (GeneOhm Sci-
ences, Sheffield, UK), and other PCR-based techniques.
However, selective media are inhibitory to MSSA and the
organism does not possess the SCC mec target used for
many of the PCR reactions. Therefore, colonization and/
or infection with MSSA may be missed upon screening.
This case report illustrates that S. aureus isolates contain-
ing highly virulent toxin genes, such as PVL, may be
deadly in patients co-infected with influenza, regardless of
the S. aureus antibiotic susceptibilities.
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